维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

12篇 您的检索式：作者名="Pluschnig"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer显示文摘	Bartsch R De Vries C Pluschnig U	2009	BMC Cancer2009，9，1：	1
	2	Prognostic value of monitoring tumour markers CA15 - 3 and CEA during fulvestrant treatment 显示文摘	Bartsch R Wenzel C Pluschnig U	2006	BMC Cancer2006，6，：	1
	3	Plasma HMGB ‐1 after the initial dose of epirubicin/docetaxel in cancer显示文摘	Tobias Arnold Anna Michlmayr Suzann Baumann Christopher Burghuber Ursula Pluschnig Rupert Bartsch Guenther Steger Michael Gnant Michael Bergmann Thomas Bachleitner‐Hofmann Rudolf Oehler	2013	Eur J Clin Invest2013，，3：	1
	4	Prognostic value of monitoring tumour markers CA15-3 and CEA during fulvestrant treatment显示文摘	Bartsch R Wenzel C Pluschnig U	2006	BMC Cancer2006，6，：	1
	5	Predicting for activity of second-line trastuzumab-based therapy in HER2-positive advanced breast cancer显示文摘	Bartsch R De Vries C Pluschnig U	2009	BMC Cancer2009，9，1：	1
	6	Temporary Placement of Self-Expanding Oesophageal Stents as Bridging for Neo-Adjuvant Therapy显示文摘	Felix B. Langer Sebastian F. Schoppmann Gerhard Prager Florian Tomaselli Ursula Pluschnig Michael Hejna Rainer Schmid Johannes Zacherl	2010	Annals of Surgical Oncology2010，，2：	1
	7	Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients显示文摘	Florian Fitzal Otto Riedl Lisa Wutzl Wolfgang Draxler Margaretha Rudas Ursula Pluschnig Leonore Handl-Zeller Peter Dubsky Thomas Bachleitner-Hofmann Günther Steger Raimund Jakesz Michael Gnant	2007	Breast Cancer Research and Treatment2007，，1：	1
	8	Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial显示文摘	Manuela Schmidinger Alexandra C. Budinsky Catharina Wenzel Gottfried J. Locker Ursula Pluschnig Thomas Brodowicz Ernst Kubista Sylvia Maca August Zabernigg Peter Ilsinger Lothar Seewann Sabine Hojas Michaela Blach Christoph C. Zielinski Guenther G. Steger	2000	Cancer Chemotherapy and Pharmacology2000，，1：	1
	9	Phase Ⅰ/Ⅱ trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer 显示文摘	Wenzel C Locker GJ Pluschnig U	2002	Cancer Chemother Pharmacol2002，50，2：	1
	10	Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment显示文摘	BARTSCH R WENZEL C PLUSCHNIG U	2006	BMC Cancer2006，26，6：	1
	11	Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol 显示文摘	Pluschnig U Haslik W Bayer G	2015	Support Care Cancer2015，23，6：	1
	12	Modified EOX (Epirubicin,Oxaliplatin and Capecitabine) as Palliative First-line Chemotherapy for Gastroesophageal Adenocarcinoma显示文摘	Pluschnig U Schoppmann SF Preusser M		0，，03：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费